Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3A-Register Zur Ambulanten Therapie Mit RAS-Inhibitoren in Patienten Mit Arterieller Hypertonie in Deutschland

NCT01454583 is registered in ClinicalTrials.gov with Stiftung Institut fuer Herzinfarktforschung as lead sponsor.

NCT NCT01454583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01454583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3A-Register Zur Ambulanten Therapie Mit RAS-Inhibitoren in Patienten Mit Arterieller Hypertonie in Deutschland
Lead sponsor
Stiftung Institut fuer Herzinfarktforschung
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2012
Enrollment
15,337 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension